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The COVID‑19 pandemic continues to have a devastating impact on Brazil. Brazil’s social, health 
and economic crises are aggravated by strong societal inequities and persisting political disarray. 
This complex scenario motivates careful study of the clinical, socioeconomic, demographic and 
structural factors contributing to increased risk of mortality from SARS‑CoV‑2 in Brazil specifically. 
We consider the Brazilian SIVEP‑Gripe catalog, a very rich respiratory infection dataset which 
allows us to estimate the importance of several non‑laboratorial and socio‑geographic factors on 
COVID‑19 mortality. We analyze the catalog using machine learning algorithms to account for likely 
complex interdependence between metrics. The XGBoost algorithm achieved excellent performance, 
producing an AUC‑ROC of 0.813 (95% CI 0.810–0.817), and outperforming logistic regression. Using 
our model we found that, in Brazil, socioeconomic, geographical and structural factors are more 
important than individual comorbidities. Particularly important factors were: The state of residence 
and its development index; the distance to the hospital (especially for rural and less developed areas); 
the level of education; hospital funding model and strain. Ethnicity is also confirmed to be more 
important than comorbidities but less than the aforementioned factors. In conclusion, socioeconomic 
and structural factors are as important as biological factors in determining the outcome of COVID‑19. 
This has important consequences for policy making, especially on vaccination/non‑pharmacological 
preventative measures, hospital management and healthcare network organization.
The COVID-19 pandemic is having a particularly devastating impact on Brazil with, at the time of writing, half 
a million registered cumulative deaths, second only to the  USA1. Brazil’s social, health and economic crises are 
aggravated by strong societal  inequities2 and political  disarray3. COVID-19 outcomes are likely to be the result of 
the interplay between patient and environmental factors. Age is now well established as the dominant determi-
nant of  mortality4–7. We have previously demonstrated the important effect of ethnicity and socioeconomic status 
in determining outcome in  Brazil2. A number of institutional and organizational effects may also be important. 
It has been shown that treatment site seems to have a substantial association with mortality, comparable to the 
effect of comorbidity, at least for intensive care  outcomes8. This suggests that institutional and organizational 
factors may be important. This is reasonable as it is likely that different hospitals may vary in their ability to 
respond to a surge in cases either because they are locally overwhelmed, experience an early influx of patients 
before surge capacity can be put into place or because they are inherently less able to expand capacity. A lim-
ited number of studies have attempted to look at this. A recent study in the United States did find evidence to 
support an association between hospital strain and increased  mortality9 for critical care patients, but not ward 
patients, and that this relationship changed over time. A similar negative impact of intensive care capacity was 
seen in  Belgium10. A full understanding of the interplay between patient and healthcare system factors is crucial 
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for rational, dynamic allocation of hospital resources as well as the targeting of both pharmacological and non-
pharmacological interventions. Healthcare systems vary substantially around the world, making local evalua-
tion important. To our knowledge, this has not previously been undertaken in Brazil. Healthcare organizational 
factors are likely to be, to some extent, co-linear with other socioeconomic predictors and their effects may be 
non-linear: The extent to which organizational effects are real or the result of a failure to completely adjust for 
other factors in a linear model is not known. This observation motivates the use of explainable machine learning 
models able to deal with complex interactions and non-linear relationships.
In this study, we use the Brazilian SIVEP-Gripe respiratory infection surveillance  dataset11 to study demo-
graphic, patient, socioeconomic and organizational structure influences on COVID-19 outcome. As depicted 
in Fig. 1, we model the linear and nonlinear correlations among the covariates using the successful XGBoost 
machine learning technique. We name ‘XCOVID-BR’ the XGBoost model that achieves the highest performance. 
The goal of this work is to provide the scientific community and, in particular, the Brazilian authorities with a 
ranking of the most important social, health and economic risk factors.
Materials and methods
We analyze COVID-19 hospital mortality using the public SIVEP-Gripe dataset (Sistema de Informação de 
Vigilância Epidemiológica da Gripe), a prospectively collected respiratory infection registry which is maintained 
by the Brazilian Ministry of Health for the purposes of recording cases of severe acute respiratory syndrome 
(SARS) across both public and private  hospitals11. We analyze data collected from February 25 to September 21, 
2020. Out of the 279,987 hospitalized patients that had a positive RT-PCR test for SARS-CoV-2, 242,679 cases 
have known outcome and age ≤110. We consider only patients who were admitted to hospital in order to be 
less sensitive to the regional variability of testing. Finally, as we are interested also in socioeconomic factors, we 
restrict our analysis to the 231,112 patients whose files contain geographic information and type of healthcare 
(public or private). See Fig. 2.
We initially consider 30 patient features including clinical (age, sex, ethnicity, comorbidities and symptoms), 
socio-geographic (education, state, municipal human development index MHDI, city type) and structural hos-
pital-level (distance from patient to hospital, time-dependent strain and funding) factors. In order to capture 
the time-varying pressure on individual hospitals, we defined ‘hospital strain’ as the number of hospitalized 
patients during the admission week divided by a metric of hospital capacity. As capacity numbers data were not 
available for all the hospitals considered, we used as a proxy the total number of hospitalizations according to 
the 2019 SIVEP-Gripe dataset. The 231,112 patients that we consider come from 1,801 different cities and from 
3,991 different hospitals. This richness allows us to disentangle the importance of a factor from the one of its 
covariates, fully considering all the correlations.
The prediction task was formulated as a binary classification problem for hospital mortality, with 0 represent-
ing death and 1 representing recovery. The analysis was performed using XGB but Logistic Regression, K-Nearest 
Neighbors, Neural Network, Random Forest and Support Vector Machine algorithms were also evaluated and 
are included in the Supplementary Materials for completeness (Section S3D). Our models are implemented in 
Python through the scikit-learn and XGB  packages12,13.
For the training and test sets, we used 80% (184,889 patients) and 20% (46,223 patients) random split with 
k = 10-fold cross validation. As metrics we consider the area under the receiver-operating characteristic curve 











Figure 1.  The XCOVID-BR machine learning model. XCOVID-BR takes as input a range of medical, 
socioeconomic and structural factors and returns as output the probability of death by COVID-19. XCOVID-BR 
can be applied to individuals, groups or whole sections of the Brazilian population.
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given classification (recovery or death). Feature importance is analyzed using the permutation method: the 
relationship between feature and target is broken via a random shuffle and feature importance is defined as 
the corresponding decrease in the AUC-ROC metric (see the Supplementary Materials, Section S3E, for more 
details and robustness tests).
The SIVEP-Gripe catalog has missing values. In the case of comorbidities or symptoms we imputed missing 
values as the clinical feature being absent for the  individual2. For the remaining variables we did not perform 
pre-processing for the XGB algorithm as the latter already imputes missing data. A table with the percentages of 
patients with missing values is available in the Supplementary Materials (Section S3C).
The study was conducted and reported in line with the Transparent Reporting of a multivariable prediction 
model for Individual Prognosis Or Diagnosis (TRIPOD)14.
Results
Our ‘XCOVID-BR’ XGBoost model achieved the highest performance of the models tested and is considered 
in the subsequent analysis. The model is publicly available at https:// github. com/ Pedro Baqui/ XCOVID- BR. We 
found that the XGBoost algorithm achieves excellent performance of AUC-ROC=0.813 (95% CI 0.810–0.817) 
compared to the logistic regression’s AUC-ROC=0.766 (95% CI 0.761–0.770, full comparison table in the Sup-
plementary Materials, Section S3D). Model calibration is shown in Fig. 3. While the difference in AUC-ROC 
between XGBoost and logistic regression may seem not large, it is in fact significant. For instance, holding speci-
ficity at 80.0%, XGBoost correctly predicted death by COVID-19 (positive condition) for 1,466 more patients 
(8.4% of the 17,357 patients) and, holding sensitivity at 80%, XGBoost correctly predicted survival for 1,971 more 
patients (6.8% of the 28,866 patients), in comparison with logistic regression. Equivalently, at 80% of specificity, 
XGBoost and logistic regression featured a sensitivity of 64.7% and 56.2%, respectively, while at 80% of sensitiv-
ity, they featured a specificity of 66.5% and 59.7%, respectively.
Figure 4 shows the importance of the features considered in this analysis, excluding symptoms as they are 
not related to the patients’ pre-infection conditions. The XCOVID-BR model shows that, in Brazil, comorbidi-
ties showed less association with outcome than socioeconomic, structural and ethnic factors, and confirms the 
well-known importance of age.
In Fig. 5 we again use the permutation method, but we split the test set between younger ( < 60 years, AUC-
ROC=0.770, 95% CI 0.763–0.777) and older ( ≥ 60 years, AUC-ROC=0.717, 95% CI 0.711–0.725) patients, 24,277 
and 21,946 patients respectively (in Brazil patients over 60 are considered  elderly2). We find that for younger 
patients the state and the number of comorbidities play a more important role than their own age (Fig. 5). On 
91,588 COVID-19 deaths out of 242,679 cases 
with known outcome and age 110
279,987 hospitalized patients in the SIVEP-Gripe 
data with SARS-CoV-2 positive RT-PCR test
231,112 patients with valid geographic and 
hospital information, as of Sep 21, 2020
Figure 2.  Flowchart of SIVEP-Gripe data used in this study. SARS-CoV-2 stands for severe acute respiratory 
syndrome coronavirus 2. SIVEP-Gripe stands for Sistema de Informação de Vigilância Epidemiológica da Gripe.
Figure 3.  Model calibration. The calibration analysis shows that mortality predicted by the XCOVID-BR model 
performs uniformly across bins of mortality.
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the other hand, for elderly patients state has a greater importance and variations in age within this group are 
disproportionately important.
As seen from the analysis of Fig. 4, hospital funding model (private or public) is an important feature. Fig-
ure 6 shows the mortality rate for patients admitted to public and private hospitals, stratified according to age 
(the dominant factor associated with outcome). For all the age bins, mortality was consistently higher in public 
hospitals.
Table 1 shows the demographic and socio-geographic characteristics and coexisting conditions among survi-
vors and non-survivors. We also show the AUC-ROC relative to the XGB algorithm for patients belonging to each 
category, the odds ratio (OR) and the corresponding p-values. Within categories, we find qualitative agreement 
between the OR values and the relative feature importance shown in Fig. 4. However, OR and feature importance 
weigh differently the various categories. For example, the OR analysis gives more significance to comorbidities. 
This highlights the beneficial use of the XGB model in coping with correlations between the covariates.
Finally, we adopt the XCOVID-BR model in order to estimate the mortality risk of specific sections of the 
Brazilian population. Given a patient’s non-laboratorial data, the XCOVID-BR model returns a probability rang-
ing from 0 (death) to 1 (recovery). One can then estimate the overall risk of a group by studying the distribution 
of the XCOVID-BR outcomes. Figure 7 shows the XCOVID-BR model applied to age and hospital subgroups 
taken from the states of Pernambuco (Northeast) and Paraná (South).
Discussion
We present, to our knowledge, the most extensive application of machine learning to COVID-19 hospital sur-
vival in Brazil. We considered the very rich SIVEP-Gripe dataset as of September 21, 2020. We confirm several 
worldwide findings but also report important sociodemographic trends specific to Brazil.
We found that XGBoost outperforms other methods including logistic regression (Supplementary Materials, 
Section S3D). This improved performance demonstrates the non-linearity and co-linearity present in the data 
and justifies the choice of a machine learning model over conventional statistical techniques. The trained model 




































Figure 4.  Relative feature importance (median and IQR) for mortality risk to COVID-19. The coloring marks 
the categories listed in Fig. 1. Feature importance is estimated via the permutation method and a logarithmic 
scale is employed for clarity.
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Using XCOVID-BR we find that socioeconomic factors are more important than comorbidities (Figs. 4 and 5), 
a scenario that seems to reflect the social inequalities present throughout Brazil. The number of comorbidities 
remains, however, the third most important feature, signaling that the interaction between comorbidities is 
a significant factor for the outcome of COVID-19 patients. We also confirm that the patient’s age is the most 
important factor. It is worth noting, that age correlates with dementia, which has been shown to increase suscep-
tibility to COVID-1915. We highlight the following factors: the state of residence and its development index, the 
distance to the hospital (very important for rural and less developed areas), the level of education, and hospital 
funding and strain. Social factors such as the level of education, correlated to income, are related to access to 
trustworthy information that may impact the susceptibility to COVID-1916. Our analysis, however, does not 
consider data from social media and news about COVID-19. Ethnicity is also confirmed to be more important 
than comorbidities in agreement with an earlier investigation that adopted mixed-effects Cox regression survival 
 analysis2. Here, we also include socio-geographic features and model non-linear interactions via XGBoost and 
find that socio-geographic features are more important than ethnicity.
These findings qualitatively agree with the results from the descriptive and odds ratio analysis (Table 1): non-
survivors are older, more likely to have been admitted to public hospitals and live in less developed cities. Sur-
vivors are more likely to be white Brazilians, with high/higher education, living in urban areas. We also confirm 
the higher proportion of non-survivors in the North and Northeast macro-regions2. Additionally, comorbidities, 
except for asthma, are more prevalent among non-survivors, especially renal and neurological diseases. The most 
common comorbidities were cardiovascular disease and diabetes.
  






































Importance for older patients
Figure 5.  Feature importance for older and younger patients. Each point represents a feature in the SIVEP-
Gripe dataset, and the axes show the relative importance for COVID-19 mortality prediction for older ( ≥ 60 
years, x axis) and younger ( < 60 years, y axis) hospitalized patients. Variables deviating from the dotted identity 
line suggests a different relative importance for the groups. The coloring marks the categories listed in Fig. 1.
Figure 6.  Mortality rate for public and privately funded hospitals, stratified according to age. The bars are 
normalized by dividing the fatalities by the total number of cases for each type of hospital funding model.
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Table 1.  Demographic and socio-geographic characteristics and coexisting conditions among survivors 
and non-survivors of COVID-19. Data are n (%) or mean (SD). The AUC-ROC value is relative to the XGB 
algorithm for patients belonging to each category. We also show the odds ratios and statistical significance for 
mortality (univariate comparisons).
Survivors Non-survivors AUC (95% CI) OR (95% CI) p value
Brazil 143889(62.3%) 87223(37.7%) 0.813[0.810, 0.817] – –
Age (years) 54.3 ± 17.7 68.6± 15.5 – – –
Sex
Women 63919(63.5%) 36700(36.5%) 0.811 [0.805, 0.816] – –
Men 79941(61.3%) 50511(38.7%) 0.815 [0.810, 0.820] 1.100 [1.082, 1.119] <0.001
Funding model
Private 35830(74.7%) 12148(25.3%) 0.843[0.832, 0.851] – –
Public 108059 (59.0%) 75075(41.0%) 0.799 [0.795, 0.802] 2.049 [2.003, 2.096] <0.001
MHDI
Very High 63888(70.0%) 27430(30.0%) 0.816[0.810, 0.823] 0.708 [0.697, 0.720] <0.001
High 72657(58.5%) 51552(41.5%) 0.802[0.797, 0.808] 1.170 [1.154, 1.187] <0.001
Medium-Low 7344 (47.1%) 8241(52.9%) 0.791[0.776, 0.809] 1.851 [1.792, 1.912] <0.001
Ethnic group
White 55040 (64.1%) 30874(35.9%) 0.813 [0.806, 0.821] 0.866 [0.851, 0.881] <0.001
Black 6585(57.5%) 4871(42.5%) 0.803 [0.780, 0.816] 1.142 [1.099, 1.186] <0.001
East Asian 1521(60.2%) 1005(39.8%) 0.789 [0.742, 0.825] 1.020 [0.941, 1.105] 0.632
Brown 38700 (57.0%) 29205(43.0%) 0.804 [0.797, 0.812] 1.165 [1.144, 1.186] <0.001
Indigenous 280 (56.6%) 215(43.4%) 0.891[0.821, 0.948] 1.185 [0.992, 1.416] 0.061
Macro-regions
North 5974(49.1%) 6192 (50.9%) 0.781[0.765, 0.796] 1.710 [1.649, 1.773] <0.001
Northeast 21830 (51.7%) 20421(48.3%) 0.800[0.791, 0.807] 1.543 [1.511, 1.576] <0.001
Central-West 11877 (63.9%) 6724 (36.4%) 0.810[0.796, 0.824] 0.934 [0.905, 0.963] <0.001
Southeast 84551 (65.4%) 44796(34.6%) 0.811[0.805, 0.816] 0.874 [0.862, 0.887] <0.001
South 19657 (68.4%) 9090 (31.6%) 0.809[0.800, 0.822] 0.763 [0.743, 0.783] <0.001
City type
Urban 124635 (62.6%) 74523 (37.4%) 0.813 [0.808, 0.818] 0.988 [0.976, 1.001] 0.067
Peri-Urban 382 (54.7%) 316 (45.3%) 0.795 [0.711, 0.859] 1.367 [1.178, 1.587] <0.001
Rural 3288 (54.0%) 2797(46.0%) 0.798 [0.769, 0.823] 1.406 [1.336, 1.480] <0.001
Education level
Illiterate 2048(39.3%) 3169(60.7%) 0.762[0.733, 0.790] 2.558 [2.415, 2.709] <0.001
Elem. school I 10912 (51.0%) 10499(49.0%) 0.773[0.759, 0.785] 1.590 [1.543, 1.639] <0.001
Elem. school II 9026(59.1%) 6242(40.9%) 0.808[0.793, 0.824] 1.143 [1.104, 1.184] <0.001
High school 18244 (71.0%) 7459(29.0%) 0.828[0.817, 0.840] 0.676 [0.656, 0.697] <0.001
Higher education 9603(77.6%) 2778(22.4%) 0.874[0.860, 0.889] 0.478 [0.457, 0.500] <0.001
Comorbidities
Cardiovascular d. 43068 (53.1%) 37983 (46.9%) 0.767[0.760, 0.774] 1.821 [1.789, 1.853] <0.001
Asthma 4453 (68.8%) 2021 (31.2%) 0.810[0.781, 0.837] 0.749 [0.710, 0.790] <0.001
Diabetes 31719 (52.2%) 29046 (47.8%) 0.758[0.750, 0.766] 1.779 [1.745, 1.812] <0.001
Pulmonary dis. 4007 (42.1%) 5500 (57.9%) 0.746[0.723, 0.772] 2.369 [2.272, 2.469] <0.001
Obesity 7161 (59.0%) 4970 (41.0%) 0.771[0.754, 0.793] 1.167 [1.125, 1.212] <0.001
Immunosuppr. 3407 (47.3%) 3795 (52.7%) 0.741[0.715, 0.766] 1.891 [1.804, 1.982] <0.001
Renal dis. 4112 (38.3%) 6632 (61.7%) 0.719[0.699, 0.738] 2.818 [2.708, 2.933] <0.001
Liver dis. 925 (40.2%) 1377 (59.8%) 0.731[0.695, 0.773] 2.499 [2.298, 2.717] <0.001
Neurological dis. 3905 (39.2%) 6068(60.8%) 0.727[0.701, 0.753] 2.701 [2.592, 2.815] <0.001
Hematologic dis. 1054 (50.5%) 1035(49.5%) 0.804[0.767, 0.851] 1.640 [1.505, 1.788] <0.001
Symptoms
Fever 99656(65.1%) 53497(34.9%) 0.813[0.808, 0.818] 0.719 [0.706, 0.732] <0.001
Vomiting 12269(67.0%) 6049(33.0%) 0.810[0.793, 0.826] 0.812 [0.786, 0.838] <0.001
Cough 110183 (65.0%) 59246(35.0%) 0.808[0.804, 0.813] 0.665 [0.653, 0.678] <0.001
Sore throat 28238(68.5%) 12979(31.5%) 0.821[0.812, 0.831] 0.729 [0.712, 0.745] <0.001
Respiratory disc. 74879(56.8%) 56912(43.2%) 0.803[0.798, 0.808] 1.767 [1.737, 1.799] <0.001
Shortness breath 96954(58.8%) 68033(41.2%) 0.802[0.797, 0.806] 1.771 [1.736, 1.807] <0.001
Diarrhea 21837(69.1%) 9746(30.9%) 0.811[0.799, 0.820] 0.714 [0.696, 0.733] <0.001
SpO2< 95% 75083(55.2%) 61021(44.8%) 0.787[0.780, 0.795] 2.209 [2.169, 2.249] <0.001
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Of course many of these variables are correlated: Patients with access to private healthcare tend to have a 
higher education and better living conditions (city development index). While the latter means that one shares 
a household with fewer people and the ready availability of basic services such as running water and sanitation, 
the former gives the possibility to work remotely. Poor literacy is likely to also impact negatively on healthcare 
access. These findings support the conclusion that socioeconomic, ethnic and geographical factors are crucial 
in order to correctly understand the pandemic in Brazil and plan adequate  measures17.
We tested the predictive performance of the XCOVID-BR model for various sub-groups of the SIVEP-Gripe 
dataset (Table 1, AUC values) and found that the performance is generally similar to the global one, except for 
a few cases such as the North macro-region, illiterate Brazilians and some groups with comorbidities. The lower 
performance relative to these sub-groups indicates that it is more difficult to forecast the evolution of the dis-
ease within certain sections of Brazilian society, possibly because there is not enough data for these sub-groups 
which may be characterized by a higher heterogeneity. In other words, these groups are more susceptible to 
COVID-19, and it is also harder to study factors underlying their COVID-19 mortality risk. We hope this result 
will be useful in motivating federal authorities in adopting effective action in order to mitigate the impact of the 
pandemic for these groups.
  survival probability
Figure 7.  Distribution of survival probability—ranging from 0 (death) to 1 (recovery)—as estimated by the 
XCOVID-BR model. We contrast typical publicly and privately funded hospitals from Pernambuco, an example 
of a region in the more socioeconomically challenged Northeast, with examples from the richer Paraná region 
in the South. Stratifying by age, the dominant clinical predictor of mortality, it is apparent that the probability 
distribution is skewed with lower mortality in the wealthier (Paraná) region and this is particularly apparent in 
younger patients and in privately-funded hospitals.
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Hospital funding model (private or public) was found to be a very important feature (Fig. 4). We indeed clearly 
observe that public healthcare suffers from a higher mortality rate across all ages (Fig. 6). This is not unexpected 
as private healthcare serves only 25% of the Brazilian population and total spending is similar to that of public 
healthcare, implying that, on average, a patient in a private hospital costs three times more than one in a public 
 hospital18. In particular, public hospitals have 1.4 ICU beds per 10 thousand inhabitants, while private hospitals 
have 4.9. This difference is more pronounced in the North and Northeast regions, with 0.9 and 1.5 beds per 10 
thousand inhabitants in public hospitals against 4.7 and 5.5 beds per 10 thousand inhabitants for private hospi-
tals,  respectively19. Complementary to a hospital’s funding is its level of strain. Our findings are in line with the 
findings of previous  studies20,21 and suggest the importance of funding public hospitals and better managing the 
healthcare network, with profound implications for policy making in Brazil.
Finally, we showed how one can use the XCOVID-BR model in order to estimate the mortality risk of spe-
cific groups of the Brazilian population. In other words, one can apply XCOVID-BR to arbitrary sections of the 
Brazilian population and estimate the differential risk from COVID-19 (Fig. 1), helping policy makers to take 
informed decisions regarding vaccination/non-pharmacological preventative measures, hospital management 
and healthcare network organization in an equitable way.
As an example, we showed how the risk distribution differs between two representative areas: The wealthier 
Paraná and more socioeconomically challenged Pernambuco (Fig. 7). The variation in probability distributions 
is striking. Accounting for age, the dominant clinical predictor of mortality, it is apparent that the probability 
distribution is heavily skewed to higher probabilities of recovery in the wealthier (Paraná) region and this is 
particularly apparent in younger patients and in privately-funded hospitals.
Although we believe our work is the most comprehensive of its kind to date in Brazil, there are limitations 
which need discussion. Possible biases from case ascertainment cannot be ruled out, in common with all obser-
vational / retrospective database research. Data completeness was generally good, however. Because of our 
selection criteria (Fig. 2), data missingness is largely confined to ethnicity (9.0%), city type (10.5%) and educa-
tion level (28.3%, see Supplementary Materials, Section S3C), values that are overall better or comparable to a 
recent large dataset from the UK (26% of data with missing ethnicity)22. We considered only patients who were 
hospitalized, since testing in the community is more likely to be biased according to local factors. However, a 
residual inhomogeneity in this population could skew our results according to local factors, even though this 
should be mitigated by the large number of diverse covariates we consider, and the use of the XGB model that 
can cope with nonlinear correlations.
Health-seeking behavior may vary across Brazil. First, late presentation may be an important determinant of 
hospital outcome. We could not address this directly as data for physiological severity at hospital presentation 
are not available, but we considered correlated socioeconomic and structural factors such as the distance to the 
hospital. Secondly, it is important to point out that we do not have data on out-of-hospital mortality, which may 
be substantial. As such, a consideration of hospital mortality is likely to underestimate the relative differences 
in risk factors, and it is plausible to assume that healthcare availability inequities would be further amplified in 
patients who are not hospitalized. In other words, it is reasonable to assume that socioeconomic and structural 
factors are even more important than the findings of this study might suggest. Urgent work is needed to better 
understand deaths occurring in the community.
The XGB model also suffers from a number of limitations, common to other machine learning models. First, 
our results, in particular feature importance, depend, to some extent, on the details of the numerical implemen-
tation. To assess this important aspect, we tested other feature importance methods (Supplementary Materials, 
Section S3E) and confirmed the higher importance of socio-geographical and hospital-specific features, as com-
pared to comorbidities. Second, supervised machine learning models such as XGB connect features to outcome 
and their success is tied to the dataset on which they are trained. Consequently, the previously discussed dataset 
limitations are also the limitations of our XGB model.
The current vaccination plan proposed by the Brazilian Ministry of  Health23 closely follows the plans devised 
by countries in Europe such as the  UK24. In particular, prioritization is mostly based on age and comorbidities. 
While these factors are undoubtedly significant, we have shown here that in Brazil they are not the sole risk 
factors and that socioeconomic and structural factors are actually as important in order to reduce COVID-19 
 mortality25–27. Based on our findings, we recommend that the Brazilian Ministry of Health should adopt vac-
cination/non-pharmacological preventative measures that are properly tailored to the complex socioeconomic 
profile of Brazil. Specifically, we recommend boosting the resources of strained public hospitals, facilitating 
access to medical care, and targeting the socio-geographic sections of Brazil that are less economically developed.
Finally, given the changing nature of the virus, with ever more frequent emergence of SARS-CoV-2 variants, 
it is worth stressing the significance of data-driven risk factor discovery. Indeed, one expects that the relative 
importance of biological and structural COVID-19 risk factors depends on case fatality rate, transmissibility 
and response to vaccination efforts of the new variants. A data driven approach seems to be an agile approach 
to understand such an ever-changing scenario.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request. SIVEP-Gripe data are publicly available at https:// opend atasus. saude. gov. br/ datas et/ bd- srag- 2020. Our 
analysis code and XCOVID-BR are available at https:// github. com/ Pedro Baqui/ XCOVID- BR.
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